Drug class
Opioid antitussive; centrally acting cough-reflex suppressant
Mechanism of action
Acts centrally on the medullary cough centre, reducing the neural signals that trigger cough. It has opioid-related pharmacology but is used primarily as an antitussive rather than as an analgesic.
General use cases
- Historically used for symptomatic treatment of non-productive (dry) cough in adults and children, including in combination cold-and-flu products.
- Pholcodine-containing medicines were withdrawn from the EU market in 2023 because use in the preceding 12 months was associated with an increased risk of peri-anaesthetic anaphylaxis to neuromuscular blocking agents. Current availability and restrictions vary by jurisdiction.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
